Syncona Investment Management Ltd.

https://www.synconaltd.com

Syncona’s purpose is to invest to extend and enhance human life. We do this by founding and building a portfolio of global leaders in life science to deliver transformational treatments to patients in areas of high unmet need. Our strategy is to found, build and fund companies around exceptional science to create a diversified portfolio of 15-20 globally leading healthcare businesses for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders. *

	Start	2018-11-21 existent
	Group	Syncona (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Murphy, Martin (Syncona CEO before Wellcome Trust Sigma project + MVM Life Science Partners + 3i + McKinsey)
	Person 2	Jonikas, Magdalena A. (Wellcome Trust 201811 Partner at Syncona Investment Management Ltd)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	8 Bloomsbury Street 2nd Floor
	City	WC1B 3SR London
		Address record changed: 2021-11-13

Basic data	Employees	n. a.

		�About Section� taken from web site of organisation on 13.11.

		Record changed: 2025-03-16